Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1714662rdf:typepubmed:Citationlld:pubmed
pubmed-article:1714662lifeskim:mentionsumls-concept:C0030657lld:lifeskim
pubmed-article:1714662lifeskim:mentionsumls-concept:C0019707lld:lifeskim
pubmed-article:1714662lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:1714662lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:1714662pubmed:issue1lld:pubmed
pubmed-article:1714662pubmed:dateCreated1991-9-18lld:pubmed
pubmed-article:1714662pubmed:abstractTextThe genomes of HIV and SIV are complex and contain several accessory genes which modulate viral replication and pathogenicity. One of these genes, vpx, is unique to the HIV-2/SIV group of viruses and encodes a virion-associated protein of unknown function. To examine the function of vpx, we constructed a vpx-deficient HIV-2 proviral clone and characterized its in vitro biological properties. Following transfection into immortalized T-cell lines, vpx-mutant HIV-2 was fully replication competent and exhibited growth kinetics and cytopathic properties equivalent to wild-type HIV-2. In addition, vpx-deficient virions were indistinguishable from wild-type HIV-2 in ultrastructure, composition of major structural proteins, and reverse transcriptase activity. In PHA-stimulated normal peripheral blood mononuclear cells (PBMCs), however, vpx-deficient virus replicated at substantially lower titers and required a 100- to 1000-fold higher inoculum to establish a productive infection. This defect was localized to early events in the viral life cycle since vpx-deficient virus exhibited a 5- to 10-fold reduction in initial (single cycle) viral DNA synthesis following acute infection of primary PBMCs. Paradoxically, in long-term (9-23 months) cultures of immortalized T-cells (SupT1) continuous high level replication of vpx-deficient, but not wild-type, virus was observed, indicating less efficient viral spread and cell killing and a more attenuated phenotype of vpx-deficient HIV-2. Taken together, these results demonstrate that vpx is required for the production of fully infectious and cytopathic HIV-2 virions and that it functions early in the viral life cycle by facilitating viral entry and/or reverse transcription. The pronounced replicative defect of vpx-deficient HIV-2 in primary PBMCs but not in short-term cultures of immortalized T-cell lines emphasizes the need to characterize the properties of nonessential HIV accessory gene products in natural target cells.lld:pubmed
pubmed-article:1714662pubmed:languageenglld:pubmed
pubmed-article:1714662pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:citationSubsetIMlld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1714662pubmed:statusMEDLINElld:pubmed
pubmed-article:1714662pubmed:monthSeplld:pubmed
pubmed-article:1714662pubmed:issn0042-6822lld:pubmed
pubmed-article:1714662pubmed:authorpubmed-author:HahnB HBHlld:pubmed
pubmed-article:1714662pubmed:authorpubmed-author:LeeS WSWlld:pubmed
pubmed-article:1714662pubmed:authorpubmed-author:ShawG MGMlld:pubmed
pubmed-article:1714662pubmed:authorpubmed-author:ConwayJ AJAlld:pubmed
pubmed-article:1714662pubmed:authorpubmed-author:KappesJ CJClld:pubmed
pubmed-article:1714662pubmed:issnTypePrintlld:pubmed
pubmed-article:1714662pubmed:volume184lld:pubmed
pubmed-article:1714662pubmed:geneSymbolvpxlld:pubmed
pubmed-article:1714662pubmed:ownerNLMlld:pubmed
pubmed-article:1714662pubmed:authorsCompleteYlld:pubmed
pubmed-article:1714662pubmed:pagination197-209lld:pubmed
pubmed-article:1714662pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:meshHeadingpubmed-meshheading:1714662-...lld:pubmed
pubmed-article:1714662pubmed:year1991lld:pubmed
pubmed-article:1714662pubmed:articleTitleHuman immunodeficiency virus type 2 vpx protein augments viral infectivity.lld:pubmed
pubmed-article:1714662pubmed:affiliationDepartment of Medicine, University of Alabama, Birmingham 35294.lld:pubmed
pubmed-article:1714662pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1714662pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1714662pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1714662lld:pubmed